04-25-2022 / Learn how gene to antibody services, including GenSciprt’s gene synthesis, codon-optimization, plasmid cloning, and plasmid preparation, support and expedite the discovery of antibody drugs.

03-29-2022 / Learn about antibody therapies undergoing FDA review during the first part of 2022 and those antibody drugs, including bispecific antibodies, at the very late stages of clinical evaluation.

10-25-2021 / Find out how iPSC-derived cerebral organoids enable the screening of FDA approved drugs to reduce pathogenic protein aggregates in association with Alzheimer’s disease.

09-05-2021 / Learn how IL3 and IL3 receptor alpha based communication between astrocytes and microglia represents a potential therapeutic target in Alzheimer’s disease

06-28-2021 / Learn about the less well-known post-translational modification AMPylation, newly developed tools to identify AMP-modified proteins, and recently identified AMPylated proteins in the brain.

05-18-2021 / Learn about the advantages and challenges of antibody-drug conjugates (ADC) as chemotherapeutics for various cancers.

04-27-2021 / The animal reservoir from SARS-CoV-2

04-26-2021 / Learn how anti-HIV vaccines are advancing towards the clinic and how investigators are devising vaccine strategies to promote anti-HIV neutralizing and non-neutralizing antibodies.

04-06-2021 / Learn how a new strategy takes advantage of a highly potent form of IL-6 to promote spinal neuron regeneration and restore function after spinal cord injury.